L-Asparaginase is commonly used as a combination chemotherapy drug for the treatment of acute lymphoblastic leukaemia (ALL) in adults and children and non-Hodgkin’s lymphoma in children (Mashburn and Wriston 1964). This evidence concerns the gene ASPG and acute lymphoblastic leukemia.